Commit To Purchase Supernus Pharmaceuticals At $5, Earn 7% Using Options
December 29, 2014 at 11:41 AM EST
Investors eyeing a purchase of Supernus Pharmaceuticals Inc (SUPN) shares, but tentative about paying the going market price of $8.40/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2016 put at the $5 strike, which has a bid at the time of this writing of 35 cents..